Carsten Jers

Dr. Carsten Jers


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MŁMateusz Łężyk
Mateusz Łężyk
CJCarsten Jers
Carsten Jers
LKLouise Kjaerulff
Louise Kjaerulff
CGCharlotte Held Gotfredsen
Charlotte Held Gotfredsen
MMMaria D. Mikkelsen
Maria D. Mikkelsen
JMJørn D. Mikkelsen
Jørn D. Mikkelsen
This paper describes the discovery of novel α-L-fucosidases and evaluation of their potential to catalyse the transglycosylation reaction leading to production of fucosylated human milk oligosaccharides. Seven novel α-L-fucosidase-encoding genes were identified by functional screening of a soil-derived metagenome library and expressed in E. coli as recombinant 6xHis-tagged proteins. All seven fucosidases belong to glycosyl hydrolase family 29 (GH 29). Six of the seven α-L-fucosidases were substrate-inhibited, moderately thermostable and most hydrolytically active in the pH range 6–7, when tested with para-nitrophenyl-α-L-fucopyranoside (pNP-Fuc) as the substrate. In contrast, one fucosidase (Mfuc6) exhibited a high pH optimum and an unusual sigmoidal kinetics towards pNP-Fuc substrate. When tested for trans-fucosylation activity using pNP-Fuc as donor, most of the enzymes were able to transfer fucose to pNP-Fuc (self-condensation) or to lactose. With the α-L-fucosidase from Thermotoga maritima and the metagenome-derived Mfuc5, different fucosyllactose variants including the principal fucosylated HMO 2’-fucosyllactose were synthesised in yields of up to ~6.4%. Mfuc5 was able to release fucose from xyloglucan and could also use it as a fucosyl-donor for synthesis of fucosyllactose. This is the first study describing the use of glycosyl hydrolases for the synthesis of genuine fucosylated human milk oligosaccharides.

11 January 2018 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
CJCarsten Jers
Carsten Jers
VRVaishnavi Ravikumar
Vaishnavi Ravikumar
MŁMateusz Łężyk
Mateusz Łężyk
ASAbida Sultan
Abida Sultan
ÅSÅsa Sjöling
Åsa Sjöling
Ivan MijakovicIvan Mijakovic
Ivan Mijakovic
Protein lysine acetylation is recognized as an important reversible post translational modification in all domains of life. While its primary roles appear to reside in metabolic processes, lysine acetylation has also been implicated in regulating pathogenesis in bacteria. Several global lysine acetylome analyses have been carried out in various bacteria, but thus far there have been no reports of lysine acetylation taking place in the important human pathogen Vibrio cholerae. In this study, we analyzed the lysine acetylproteome of the human pathogen V. cholerae V52. By applying a combination of immuno-enrichment of acetylated peptides and high resolution mass spectrometry, we identified 3402 acetylation sites on 1240 proteins. Of the acetylated proteins, more than half were acetylated on two or more sites. As reported for other bacteria, we observed that many of the acetylated proteins were involved in metabolic and cellular processes and there was an over-representation of acetylated proteins involved in protein synthesis. Of interest, we demonstrated that many global transcription factors such as CRP, H-NS, IHF, Lrp and RpoN as well as transcription factors AphB, TcpP, PhoB, and ToxR, involved in direct regulation of virulence in V. cholerae were acetylated. The overall level of acetylation increased during growth and was higher in stationary phase. In conclusion, this is the first global protein lysine acetylome analysis of V. cholerae and should constitute a valuable resource for in-depth studies of the impact of lysine acetylation in pathogenesis and other cellular processes.

14 January 2014 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
ISInês R. Silva
Inês R. Silva
CJCarsten Jers
Carsten Jers
HOHarm Otten
Harm Otten
CNChristian Nyffenegger
Christian Nyffenegger
DLDorte M. Larsen
Dorte M. Larsen
SLSine Larsen
Sine Larsen

31 August 2013 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
ISInês R. Silva
Inês R. Silva
DLDorte M. Larsen
Dorte M. Larsen
CJCarsten Jers
Carsten Jers
PDPatrick Derkx
Patrick Derkx
AMAnne S. Meyer
Anne S. Meyer
JMJørn Mikkelsen
Jørn Mikkelsen

3 February 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CNChristian Nyffenegger
Christian Nyffenegger
RNRune Thorbjørn Nordvang
Rune Thorbjørn Nordvang
CJCarsten Jers
Carsten Jers
AMAnne S. Meyer
Anne S. Meyer
JMJørn Dalgaard Mikkelsen
Jørn Dalgaard Mikkelsen
A sialidase (EC 3.2.1.18) from the non-pathogenic Trypanosoma rangeli, TrSA, has been shown to exert trans-sialidase activity after mutation of five specific amino acids in the active site (M96V, A98P, S120Y, G249Y, Q284P) to form the so-called TrSA5mut enzyme. By computational and hypothesis driven approaches additional mutations enhancing the trans-sialidase activity have been suggested. In the present work, we made a systematic combination of these mutations leading to seven new variants of the T. rangeli sialidase, having 6–16 targeted amino acid mutations. The resulting enzyme variants were analyzed via kinetics for their ability to carry out trans-sialidase reaction using CGMP and D-lactose as substrates. The sialidase variants with 15 and 16 mutations, respectively, exhibited significantly improved trans-sialidase activity for D-lactose sialylation. Our results corroborate, that computational studies of trans-glycosylation can be a valuable input in the design of novel trans-glycosidases, but also highlight the importance of experimental validation in order to assess the performance. In conclusion, two of the seven mutants displayed a dramatic switch in specificity from hydrolysis towards trans-sialylation and constitute the most potent trans-sialidase mutants of TrSA described in literature to date.

15 February 2017 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
CJCarsten Jers
Carsten Jers
Mikael StrubeMikael Strube
Mikael Strube
MCMette D. Cantor
Mette D. Cantor
BNBea K. K. Nielsen
Bea K. K. Nielsen
OSOle B. Sørensen
Ole B. Sørensen
AMAnne S. Meyer
Anne S. Meyer